Abstract
Repetitive transcranial magnetic stimulation (rTMS) has been found to be a promising noninvasive therapeutic tool for a variety of neuropsychiatric conditions. Therapeutic utility of rTMS was classified to have class A evidence for treatment of depression and chronic pain. In different stimulation protocols intervals have been introduced between high frequency (HF) trains for safety concerns and other practical reasons, which might affect efficacy of rTMS therapy.
Original language | English |
---|---|
Pages (from-to) | e275-e276 |
Number of pages | 2 |
Journal | Clinical Neurophysiology |
Volume | 128 |
Issue number | 9 |
DOIs | |
State | Published - 1 Sep 2017 |